Hyalgan is an injectable treatment for knee pain associated with osteoarthritis when simple painkillers or exercise and physical therapy are not enough.
Following the transfer of the rights, Fidia will get the right to promote, distribute and sell Hyalgan in the US through its wholly owned subsidiary, Fidia Pharma USA.
Fidia is the owner and manufacturer of Hyalgan.